F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
311.4 |
mg/dl |
10.8 |
35.82 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11463 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
253.8 |
mg/dl |
12.6 |
41.79 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11439 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 10 |
268.14 |
mg/dl |
14.16 |
44.78 |
serum triglyceride analysis |
tail vein |
|
|
0 |
|
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11478 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
65 days
| 11 |
0.06 |
mg/dl |
0.01 |
0.03 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
30 |
min |
|
67630 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
95 days
| 11 |
0.07 |
mg/dl |
0.02 |
0.06 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
30 |
min |
|
67640 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
100.8 |
mg/dl |
5.4 |
17.91 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11429 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
127.8 |
mg/dl |
3.6 |
11.94 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11432 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
17654.55 |
(mg/dl) x min |
636.36 |
2110.58 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11447 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
185 days
| 10 |
0.04 |
mg/dl |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
tail vein |
0.0 |
|
0 |
|
|
67646 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
313.2 |
mg/dl |
12.6 |
41.79 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11441 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
95 days
| 11 |
0.01 |
mg/dl |
0.0 |
0.02 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
|
67633 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
91.8 |
mg/dl |
1.8 |
5.97 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11456 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
190.8 |
mg/dl |
9.0 |
29.85 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11460 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum high density lipoprotein cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood HDL cholesterol amount |
male |
185 days
| 10 |
40.54 |
mg/dl |
1.16 |
3.66 |
serum high-density lipoprotein-cholesterol measurement test |
tail vein |
|
|
0 |
|
N-geneous HDL-c kit (Biomed-RK, Jonkoping, Sweden) |
11471 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
65 days
| 11 |
0.07 |
mg/dl |
0.01 |
0.03 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
15 |
min |
|
67627 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum total cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood cholesterol amount |
male |
185 days
| 10 |
85.71 |
mg/dl |
1.93 |
6.1 |
serum total cholesterol measurement test |
tail vein |
|
|
0 |
|
Vitros CHOL slides (Johnson & Johnson, Rochester, NY) |
11475 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
185 days
| 10 |
111.6 |
mg/dl |
1.8 |
5.69 |
blood glucose analysis |
tail vein |
|
|
0 |
|
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11481 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
99.0 |
mg/dl |
3.6 |
11.94 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11457 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
14072.73 |
(mg/dl) x min |
363.64 |
1206.05 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11469 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
145.8 |
mg/dl |
9.0 |
29.85 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11435 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
95 days
| 11 |
0.07 |
mg/dl |
0.02 |
0.06 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
15 |
min |
|
67636 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
65 days
| 11 |
0.01 |
mg/dl |
0.0 |
0.0 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
|
67624 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
86.4 |
mg/dl |
1.8 |
5.97 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11452 |
85 |